Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomised, Double-blind, Placebo-controlled Multicentre Clinical Trial of Inhaled Molgramostim in Autoimmune Pulmonary Alveolar Proteinosis Patients

NCT02702180 is registered in ClinicalTrials.gov with Savara Inc. as lead sponsor.

NCT NCT02702180
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02702180 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomised, Double-blind, Placebo-controlled Multicentre Clinical Trial of Inhaled Molgramostim in Autoimmune Pulmonary Alveolar Proteinosis Patients
Lead sponsor
Savara Inc.
Phase
Phase 2
Overall status
Completed
Start date
March 21, 2016
Completion date
September 27, 2019
Enrollment
139 (actual)
Sites
30

Conditions

As the registry lists them; a condition with its own page is linked.

autoimmune pulmonary alveolar proteinosis